Summary | Valeant Pharmaceuticals International Inc. is in the
market for a new finance chief, as Howard Schiller plans to
step down from the post.Mr. Schiller, a former Goldman Sachs
executive, said his decision to leave the company after a
little more than three years as CFO was personal, not a signal
the company's acquisitive streak is coming to an end. ...
market for a new finance chief, as Howard Schiller plans to
step down from the post.Mr. Schiller, a former Goldman Sachs
executive, said his decision to leave the company after a
little more than three years as CFO was personal, not a signal
the company's acquisitive streak is coming to an end. ...
blogs.wsj.com | 30 April 2015